The New England journal of medicine 2009-01-08

Glycemic control in patients with insulinoma treated with everolimus.

Related Questions

Do you have a preferred systemic agent for patients with metastatic, unresectable, functional neuroendocrine tumors, such as an insulinoma, if the goal is to get a quick response?

Medical Oncology · UH Seidman Cancer Center, Case Western Reserve University

The management of metastatic unresectable neuroendocrine tumors depends on many factors including functionality, tumor burden, primary tumor, and SS expression. Usually, part of the management will be SSA to control hormonal secretion, however, we should be careful in patients with insulinoma. While...